ENLV Enlivex Ltd.
Finance Services · Nasdaq · SEC CIK 1596812 · Fiscal year ends 12/31
Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q22024-06-30 | 2024Q12024-03-31 | 2023Q22023-06-30 | 2023Q12023-03-31 | 2022Q22022-06-30 | 2022Q12022-03-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | — | — | — | — | — | — | — | — |
| R&D expense | $2.14M | — | $2.00M | — | $5.04M | — | $4.11M | — |
| SG&A expense | $937,000 | — | $987,000 | — | $1.61M | — | $1.76M | — |
| Operating income | -$3.08M | — | -$2.99M | — | -$6.65M | — | -$5.87M | — |
| Net income | -$1.87M | -$3.45M | -$3.10M | -$4.14M | -$6.79M | -$7.22M | -$9.91M | -$8.22M |
| EBITDA | -$2.99M | — | -$2.83M | — | — | — | -$5.70M | — |
| EPS (basic) | -0.08 | — | -0.16 | — | -0.37 | — | -0.54 | — |
| EPS (diluted) | -0.08 | — | -0.16 | — | -0.37 | — | -0.54 | — |
| Weighted avg. shares (diluted) | 23.86M | — | 19.55M | — | — | — | — | — |
| Banking | ||||||||
| Deposits | — | — | — | — | $2.43M | — | $18.02M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $1.89M | — | $4.17M | — | $3.86M | — | $20.55M | — |
| Short-term investments | $6,000 | — | $228,000 | — | $25.44M | — | — | — |
| Current assets | $21.32M | — | $28.57M | — | $30.79M | — | $65.05M | — |
| PP&E, net | $490,000 | — | $1.16M | — | $9.57M | — | $6.52M | — |
| Total assets | $22.60M | — | $31.90M | — | $53.03M | — | $77.34M | — |
| Current liabilities | $3.33M | — | $2.84M | — | $4.99M | — | $4.21M | — |
| Short-term debt | — | — | — | — | $25.44M | — | $42.33M | — |
| Long-term debt | — | — | — | — | $7.16M | — | — | — |
| Total debt | — | — | — | — | $32.60M | — | — | — |
| Total liabilities | $3.54M | — | $3.34M | — | $8.69M | — | $8.86M | — |
| Shareholders' equity | $19.05M | $20.63M | $28.56M | $26.85M | $44.34M | $50.57M | $68.49M | $77.65M |
| Net debt | — | — | — | — | $28.74M | — | — | — |
| Shares outstanding | 23.86M | — | 20.88M | — | 18.59M | — | 18.38M | — |
| Cash flow statement | ||||||||
| Operating cash flow | — | — | — | — | — | — | — | — |
| Depreciation & amortization | $85,000 | — | $160,000 | — | — | — | $176,000 | — |
| Stock-based compensation | $295,000 | — | $388,000 | — | $511,000 | — | $697,000 | — |
Free plan shows the latest 8 periods; Pro shows all 20 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.